University of Kansas Cancer Center (Westwood)

Westwood, KS

Sorting 2 by

Accepting patients

OPN-662

A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerability of OPN-6602 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and/or Refractory Multiple Myeloma
Learn more
  • BET Inhibitor
  • Phase 1
  • Has results

Accepting patients

TECVAYLI

A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma
Learn more
  • CELMoD
  • Bispecific Antibody
  • BCMA
  • Phase 1
2 hidden based on your filters.Show All